cicletanine has been researched along with 6-ketoprostaglandin f1 alpha in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (53.85) | 18.7374 |
| 1990's | 6 (46.15) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adam, A; Bascands, JL; Berthet, P; Bompart, G; Emond, C; Girolami, JP; Pecher, C; Rakotoarivony, J; Tarrade, T | 1 |
| Braquet, P; Hellegouarch, A; Tosaki, A | 1 |
| Braquet, P; Tosaki, A; Viossat, I | 1 |
| Bourgain, RH; Braquet, P; Deby, C; Deby-Dupont, G; Garay, RP; Pincemail, J | 1 |
| Bourgain, RH; Deby, C | 1 |
| Bosquet, D; Bourgain, R; Braquet, P; Deby, C; Deby-Dupont, G; Pincemail, J | 1 |
| Benzoni, D; Cuisinaud, G; Ferry, N; Geoffroy, J; Pozet, N; Sassard, J; Zech, PY | 1 |
| Guillen, JC; Jouve, R; Langlet, F; Lanti, M; Puddu, PE; Rolland, PH; Serradimigni, A | 1 |
| Frölich, JC; Guinot, P | 1 |
| Bonta, IL; Braquet, P; Elliott, GR; van Batenburg, M | 1 |
| Imanishi, M; Kimura, G; Kuramochi, M; Matsuoka, H; Omae, T; Tsuji, T; Yasu, T | 1 |
| Imanishi, M; Yasu, T | 1 |
| Katsumata, H; Nakamoto, H; Ohishi, A; Sakaguchi, H; Saruta, T; Suzuki, H | 1 |
2 trial(s) available for cicletanine and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
Study of the effects of cicletanine on prostanoids.
Topics: 6-Ketoprostaglandin F1 alpha; Administration, Oral; Dinoprost; Dinoprostone; Diuretics; Drug Administration Schedule; Drug Tolerance; Humans; Prostaglandins; Prostaglandins E; Prostaglandins F; Pyridines; Random Allocation; Thromboxane B2; Urination | 1985 |
Effects of cicletanine on prostaglandin I2 and E2 levels in patients with essential hypertension.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Antihypertensive Agents; Blood Pressure; Dinoprostone; Double-Blind Method; Epoprostenol; Female; Humans; Hypertension; Male; Middle Aged; Pyridines; Sodium | 1997 |
11 other study(ies) available for cicletanine and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
Protective effect of cicletanine on hypertension-induced decreases in the renal kallikrein-kinin and prostaglandin systems in stroke-prone spontaneously hypertensive rats.
Topics: 6-Ketoprostaglandin F1 alpha; Amino Acid Sequence; Animals; Antihypertensive Agents; Blood Pressure; Cerebrovascular Disorders; Dinoprostone; Hypertension; Kallikrein-Kinin System; Kallikreins; Kidney; Kinins; Male; Molecular Sequence Data; Phospholipases A; Prostaglandins; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1992 |
Cicletanine and reperfusion injury: is there any correlation between arrhythmias, 6-keto-PGF1 alpha, thromboxane B2, and myocardial ion shifts (Na+, K+, Ca2+, and Mg2+) induced by ischemia/reperfusion in isolated rat heart.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Anti-Arrhythmia Agents; Body Water; Calcium; Coronary Disease; Diuretics; Electrocardiography; In Vitro Techniques; Magnesium; Myocardial Reperfusion Injury; Myocardium; Potassium; Pyridines; Rats; Rats, Inbred WKY; Sodium; Thromboxane B2 | 1991 |
Effect of cicletanine on reperfusion-induced arrhythmias and its relation to 6-keto-PGF1 alpha and thromboxane B2 release.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Diuretics; Epoprostenol; Male; Myocardial Reperfusion Injury; Myocardium; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Thromboxane A2; Thromboxane B2 | 1991 |
Modulation of in vivo generation of prostanoids by drugs affecting membrane ion transport.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acid; Arachidonic Acids; Blood Pressure; Bumetanide; Diuretics; Ethylmaleimide; Furosemide; Insulin; Male; Models, Biological; Potassium; Prostaglandin-Endoperoxide Synthases; Pyridines; Rabbits; Thromboxane B2; Time Factors; Verapamil | 1988 |
Enhancement of prostacyclin generation by cicletanine (an in vivo investigation).
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Antihypertensive Agents; Arachidonic Acid; Arachidonic Acids; Cytochrome P-450 Enzyme System; Diuretics; Epoprostenol; Furosemide; Intramolecular Oxidoreductases; Isomerases; Pyridines; Rabbits; Rats; Thromboxane A2; Thromboxane B2; Tranylcypromine | 1988 |
[Increase of the prostacyclin/thromboxane A2 ratio in the plasma of rabbits treated with cicletanine, a new antihypertensive agent].
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Antihypertensive Agents; Arachidonic Acid; Arachidonic Acids; Blood Pressure; Diuretics; Epoprostenol; Kinetics; Male; Pyridines; Rabbits; Thromboxane A2; Thromboxane B2 | 1988 |
Influence of renal insufficiency on the pharmacokinetics of cicletanine and its effects on the urinary excretion of electrolytes and prostanoids.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Creatinine; Diuretics; Electrolytes; Female; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Middle Aged; Prostaglandins; Pyridines; Thromboxane B2 | 1988 |
Effects of cicletanine in the left circumflex coronary artery occlusion-reperfusion canine model of sudden death: analysis of 107 experiments using Cox's proportional hazards model.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Antihypertensive Agents; Arrhythmias, Cardiac; Blood Pressure; Coronary Disease; Death, Sudden; Diuretics; Dogs; Electrocardiography; Female; Heart Rate; Heart Ventricles; Male; Perfusion; Pyridines; Statistics as Topic | 1988 |
Changes in resident rat peritoneal macrophage eicosanoid release, induced by altering the buffer K+/Na+ ratio, are Ca2+ dependent.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acid; Arachidonic Acids; Buffers; Calcium; Dinoprostone; Diuretics; Eicosanoic Acids; Macrophages; Potassium; Prostaglandin-Endoperoxide Synthases; Prostaglandins E; Pyridines; Rats; Sodium; Thromboxane B2 | 1985 |
Short-term increase in prostaglandin I2 synthesis caused by cicletanine in patients with essential hypertension.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Antihypertensive Agents; Dinoprostone; Epoprostenol; Female; Humans; Hypertension; Male; Middle Aged; Pyridines; Renin | 1995 |
Effects of cicletanine on the progression of renal failure in 5/6 nephrectomized hypertensive rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Creatinine; Dinoprostone; Disease Progression; Dose-Response Relationship, Drug; Hypertension, Renal; Male; Nephrectomy; Pyridines; Rats; Rats, Inbred SHR; Renal Insufficiency | 1999 |